Meischl, Tobias
Schmid-Scherzer, Karin
Vafai-Tabrizi, Florian
Wurzinger, Gert
Traunmüller-Wurm, Eva
Kutics, Kristina
Rauter, Markus
Grabcanovic-Musija, Fikreta
Müller, Simona
Kaufmann, Norbert
Löffler-Ragg, Judith
Valipour, Arschang
Funk, Georg-Christian
Article History
Received: 22 March 2022
Accepted: 18 January 2023
First Online: 27 January 2023
Declarations
:
: The study was approved by the human research ethics committee of the City of Vienna on January 31, 2012 (number EK11-248-0112). The study protocol conforms to the ethical guidelines of the Declaration of Helsinki and the Good Scientific Practice guidelines of the Medical University of Vienna. Written, informed consent was obtained from all patients who were included in the study.
: Not applicable.
: TM received speaker fees from Chiesi and Janssen-Cilag; and travel support from CSL Behring, Chiesi, Jazz Pharmaceuticals and Janssen-Cilag. KSS received speaker fees from Chiesi, CSL Behring and Grifols. GW and AV received speaker fees and consultancy fees from Chiesi. NK received speaker fees from Chiesi. JLR received consultancy fees from CSL Behring. GCF received speaker fees and consultancy fees from Chiesi and CSL Behring. FVT, ETW, KK, MR, FGM, and SM declare no potential conflicts of interest.